• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟碱诱导荨麻疹:戒烟治疗中 1 例报告。

Cytisine induced urticaria : a case report during a smoking cessation treatment.

机构信息

Department of Medicine, Addiction Medicine Unit, Verona University Hospital, 37134 Verona, Italy.

a:1:{s:5:"en_US";s:146:"Unit of Addiction Medicine, Department of Internal Medicine, Integrated University Hospital of Verona, Policlinico "G.B. Rossi", Verona, Italy";}.

出版信息

Acta Biomed. 2022 Jun 22;93(S1):e2022073. doi: 10.23750/abm.v93iS1.12450.

DOI:10.23750/abm.v93iS1.12450
PMID:35731167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10510958/
Abstract

Cytisine is considered to be the oldest medication for smoking cessation and has been used for this purpose in some Eastern/Central European and Central Asian countries for over 50 years. Several sources points towards cytisine's efficacy and effectiveness; it's well tolerated when taken at the recommended dose, and adverse events reported in trials are typically non-serious and self-limiting gastrointestinal and sleep disturbances. We report a suspect case of urticaria during treatment for smoking cessation with cytisine in a woman of 48 years treated for smoking at the Unit of Addiction Medicine, Department of Internal Medicine, Hospital Trust of Verona, Italy.  The therapeutic protocol of cytisine that was used is of the "inductive" type; it consists in gradually increasing the daily capsules taken, with a parallel reduction in the number of cigarettes smoked until complete cessation between the fifth and ninth day of therapy (quit day) The number of capsules taken is then gradually reduced. She was treated for the firsts three days with betamethasone 1 mg/die, on the advice of her general practitioner, and suspended Cytisine. A week later the patient showed signs of recovery.

摘要

烟碱是被认为是最古老的戒烟药物,在一些东欧、中欧和中亚国家已经使用了超过 50 年。有几个来源指出了烟碱的疗效和有效性;在推荐剂量下使用时,它的耐受性良好,试验中报告的不良事件通常是非严重的,且自我限制的胃肠道和睡眠障碍。我们报告了一例疑诊的荨麻疹病例,该病例发生在意大利维罗纳医院信托的内科成瘾医学科,一名 48 岁女性因吸烟而使用烟碱戒烟治疗。使用的烟碱治疗方案是“诱导”型的;它包括逐渐增加每天服用的胶囊数量,同时减少吸烟数量,直到治疗第 5 天至第 9 天(戒烟日)完全停止吸烟。然后逐渐减少胶囊的数量。根据她的全科医生的建议,她在前三天接受了 1 毫克/天的倍他米松治疗,并暂停了烟碱治疗。一周后,患者出现了康复迹象。

相似文献

1
Cytisine induced urticaria : a case report during a smoking cessation treatment.烟碱诱导荨麻疹:戒烟治疗中 1 例报告。
Acta Biomed. 2022 Jun 22;93(S1):e2022073. doi: 10.23750/abm.v93iS1.12450.
2
The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.在澳大利亚人群中,烟碱与伐尼克兰戒烟的效果、安全性和成本效益比较:一项随机对照非劣效性试验的研究方案。
Addiction. 2019 May;114(5):923-933. doi: 10.1111/add.14541. Epub 2019 Feb 3.
3
Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.烟碱与伐伦克林戒烟效果的随机临床试验。
JAMA. 2021 Jul 6;326(1):56-64. doi: 10.1001/jama.2021.7621.
4
Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.烟碱与伐尼克兰用于新西兰毛利人(新西兰原住民)及其大家庭戒烟的比较:一项随机非劣效性试验的方案。
Addiction. 2019 Feb;114(2):344-352. doi: 10.1111/add.14449. Epub 2018 Nov 9.
5
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2011 Feb 16(2):CD006103. doi: 10.1002/14651858.CD006103.pub5.
6
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2010 Dec 8(12):CD006103. doi: 10.1002/14651858.CD006103.pub4.
7
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.与伐尼克兰相比,金雀花碱用于戒烟的临床疗效和成本效益如何?一项系统评价和经济学评估。
Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330.
8
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.
9
Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial.烟碱与伐尼克兰用于新西兰毛利人戒烟的比较:一项随机对照试验。
Addiction. 2021 Oct;116(10):2847-2858. doi: 10.1111/add.15489. Epub 2021 May 4.
10
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD006103. doi: 10.1002/14651858.CD006103.pub3.

引用本文的文献

1
Cytisine as an Emerging Tool for Smoking Cessation and Addiction Treatment.金雀花碱作为戒烟和成瘾治疗的新兴工具。
Iran J Public Health. 2024 Dec;53(12):2823-2824.
2
Method for determination of cytisine in post-mortem biological matrices and its application to two forensic cases.死后生物基质中金雀花碱的测定方法及其在两起法医案件中的应用。
Forensic Toxicol. 2025 Jul;43(2):385-394. doi: 10.1007/s11419-024-00710-3. Epub 2024 Dec 19.

本文引用的文献

1
Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.烟碱碱用于尼古丁成瘾治疗:药理学、治疗学综述及戒烟临床试验证据的更新。
Addiction. 2019 Nov;114(11):1951-1969. doi: 10.1111/add.14721. Epub 2019 Jul 19.
2
Getting cytisine licensed for use world-wide: a call to action.使金雀花碱在全球范围内获得使用许可:行动呼吁。
Addiction. 2016 Nov;111(11):1895-1898. doi: 10.1111/add.13464. Epub 2016 Jul 17.
3
Cytisine versus nicotine for smoking cessation.烟碱与野靛碱用于戒烟的效果比较。
N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764.
4
Cytisine, the world's oldest smoking cessation aid.金雀花碱,世界上最古老的戒烟辅助药物。
BMJ. 2013 Aug 23;347:f5198. doi: 10.1136/bmj.f5198.
5
Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.金雀花碱用于治疗尼古丁成瘾:从分子到治疗效果
Pharmacol Rep. 2006 Nov-Dec;58(6):777-98.
6
Cytisine for smoking cessation: a literature review and a meta-analysis.金雀花碱用于戒烟:一项文献综述与荟萃分析
Arch Intern Med. 2006;166(15):1553-9. doi: 10.1001/archinte.166.15.1553.
7
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.伐尼克兰:一种用于戒烟的α4β2烟碱型受体部分激动剂。
J Med Chem. 2005 May 19;48(10):3474-7. doi: 10.1021/jm050069n.